

Cover Story
By Matthew Bin Han Ong
After an examination of the causes of an avalanche of grant applications directed at NCI, institute officials found that new applications largely come from principal investigators who are switching their research focus to cancer. No other NIH institute or center faces such pressure.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for December 2019
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- White House announces “TrumpRx,” a new prescription drug website
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR